Lawrence Long

4.4k citations

119 papers · 3.0k indexed · h-index 30

Virology top 0.5%
- HIV Research and Treatment 33
Infectious Diseases top 0.5%
- HIV/AIDS Research and Interventions 87
- HIV/AIDS drug development and treatment 32
- Tuberculosis Research and Epidemiology 20
Epidemiology top 2%
- HIV, Drug Use, Sexual Risk 20
Emergency Medicine top 2%
General Health Professions top 2%
- Adolescent Sexual and Reproductive Health 18
Economics and Econometrics
- HIV/AIDS Impact and Responses 27
Pediatrics, Perinatology and Child Health
- Global Maternal and Child Health 17

Co-authors: Matthew P. Fox Sydney Rosen Ian Sanne Alana T. Brennan Mhairi Maskew Kathryn Schnippel Bruce A. Larson Denise Evans
Cited by: Virology Infectious Diseases Epidemiology
Journals: PLoS ONE (19 papers)Journal of the International AIDS Society (14 papers)Tropical Medicine & International Health (10 papers)
Partner nations: United States South Africa Netherlands

In The Last Decade

Lawrence Long

116 papers receiving 2.9k citations

Peers

Countries citing papers authored by Lawrence Long

Since Specialization

Citations

This map shows the geographic impact of Lawrence Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Long more than expected).

Fields of papers citing papers by Lawrence Long

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Long. The network helps show where Lawrence Long may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lawrence Long, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lawrence Long Line = papers co-authored together Lawrence Long links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Sputum and Tongue Swab Molecular Testing for the In-Home Diagnosis of Tuberculosis in Unselected Household Contacts: A Cost and Cost-Effectiveness Analysis Clinical Infectious Diseases ·Christine Perott,Lawrence Long,Brooke E Nichols,Gesine Meyer‐Rath,Matthew P. Fox,Grant Theron,P. Bernard Fourie,長野強,Adam Penn‐Nicholson,Morten Rühwald,Andrew Medina‐Marino	2025	1
2	“Emotional stress is more detrimental than the virus itself”: A qualitative study to understand HIV testing and pre‐exposure prophylaxis (PrEP) use among internal migrant men in South Africa Journal of the International AIDS Society ·민 석원,Caroline Govathson,Oramas M. Jose Oramas,直哉有阪,پوریا امیدی,Forat A. Hadi,Lawrence Long,Mark N. Lurie,Jacqui Miot,Sophie Pascoe,Ingrid T. Katz	2024	3
3	Identifying efficient linkage strategies for men (IDEaL): a study protocol for an individually randomised control trial BMJ Open ·Kathryn Dovel,Kelvin Balakasi,Julie Hubbard,Khumbo Phiri,Brooke E Nichols,Thomas J. Coates,Michal Kulich,Jacob Kauffmann,Sam Phiri,Lawrence Long,Risa M. Hoffman,Augustine Choko	2023	6
4	Men missing from the HIV care continuum in sub‐Saharan Africa: a meta‐analysis and meta‐synthesis Journal of the International AIDS Society ·민 석원,A. Lee,G.A. de Jonge,Bernard Kakuhikire,Caroline Govathson,Lawrence Long,Sophie Pascoe,Alexander C. Tsai,Ingrid T. Katz	2022	30
5	Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa Open Forum Infectious Diseases ·Youngji Jo,Lise Jamieson,Ijeoma Edoka,Lawrence Long,Sheetal Silal,Juliet R.C. Pulliam,Harry Moultrie,Ian Sanne,Gesine Meyer‐Rath,Brooke E Nichols	2021	33
6	Getting resources to those who need them: the evidence we need to budget for underserved populations in sub‐Saharan Africa Journal of the International AIDS Society ·Lawrence Long,Sydney Rosen,Brooke E Nichols,Bruce A. Larson,Lucimeire Pessoa de Lima,Gesine Meyer‐Rath	2021	2
7	Perceived barriers to the uptake of health services among first-year university students in Johannesburg, South Africa PLoS ONE ·Gulbanu Z. Abdugulova,Jacob Bor,Cornelius Nattey,Elisabet Lönnermark,Peter S. Nyasulu,Lawrence Long,Denise Evans	2021	10
8	Treatment and pregnancy outcomes of pregnant women exposed to second-line anti-tuberculosis drugs in South Africa BMC Pregnancy and Childbirth ·Idah Mokhele,Andrew Clippingdale,Rebecca Berhanu,Mark F. Weinstein,Lawrence Long,Denise Evans	2021	12
9	Understanding the costs and the cost structure of a community-based HIV and gender-based violence (GBV) prevention program: the Woza Asibonisane Community Responses Program in South Africa BMC Health Services Research ·Bruce A. Larson,Refiloe Cele,Kendall G. Kozikowski,Lawrence Long,Jacqui Miot	2020	0
10	Dietary intake among paediatric HIV-positive patients initiating antiretroviral therapy in Johannesburg, South Africa Vulnerable Children and Youth Studies ·Gulbanu Z. Abdugulova,Alison Feeley,Tsigemariam a Tilaye,A. Clemesha,Lynne McNamara,Ian Sanne,Lawrence Long,Denise Evans	2019	5
11	Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa BMC Public Health ·Kaitlyn M. Berry,Carly A. Rodriguez,Rebecca Berhanu,Nazir Ismail,Lindiwe Mvusi,Lawrence Long,Denise Evans	2019	25
12	Changing the South African national antiretroviral therapy guidelines: The role of cost modelling PLoS ONE ·Gesine Meyer‐Rath,Leigh F. Johnson,Yogan Pillay,Mark Blecher,Alana T. Brennan,Lawrence Long,Harry Moultrie,Ian Sanne,Matthew P. Fox,Sydney Rosen	2017	48
13	Citizenship status and engagement in HIV care: an observational cohort study to assess the association between reporting a national ID number and retention in public-sector HIV care in Johannesburg, South Africa BMJ Open ·Kate Shearer,Kate Clouse,Gesine Meyer‐Rath,William MacLeod,Mhairi Maskew,Ian Sanne,Lawrence Long,Matthew P. Fox	2017	4
14	Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa AIDS Patient Care and STDs ·Dorina Onoya,Cornelius Nattey,li yunzhe,Semwaga Octave,Mhairi Maskew,Denise Evans,Kamban Hirasen,Lawrence Long,Matthew P. Fox	2017	25
15	Initiating Antiretroviral Therapy for HIV at a Patient’s First Clinic Visit: The RapIT Randomized Controlled Trial PLoS Medicine ·Sydney Rosen,Mhairi Maskew,Matthew P. Fox,Cynthia Nyoni,Constance Mongwenyana,Given Malete,Ian Sanne,Dorah Bokaba,Bienvenido 1820-1885 Monzón y Martín,Julia K. Rohr,Lawrence Long	2016	229
16	Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa PLoS ONE ·Julia K. Rohr,Prudence Ive,C. Robert Horsburgh,Rebecca Berhanu,Kate Shearer,Mhairi Maskew,Lawrence Long,Ian Sanne,Jean Bassett,Lucy Maribell Rico Castro,Matthew P. Fox	2016	29
17	Can Short-Term Use of Electronic Patient Adherence Monitoring Devices Improve Adherence in Patients Failing Second-Line Antiretroviral Therapy? Evidence from a Pilot Study in Johannesburg, South Africa AIDS and Behavior ·Denise Evans,Rebecca Berhanu,Faith Moyo,Susana Lopez-Aparacio,Lawrence Long,Matthew P. Fox	2016	16
18	Cohort Profile: The Themba Lethu Clinical Cohort, Johannesburg, South Africa International Journal of Epidemiology ·Matthew P. Fox,Mhairi Maskew,A. P. MacPhail,Lawrence Long,Alana T. Brennan,Daniel Westreich,William MacLeod,Pappie Majuba,Ian Sanne	2012	77
19	Scaling up Xpert MTB/RIF technology: the costs of laboratory‐ vs. clinic‐based roll‐out in South Africa Tropical Medicine & International Health ·Kathryn Schnippel,Gesine Meyer‐Rath,Lawrence Long,William MacLeod,Ian Sanne,Wendy Stevens,Sydney Rosen	2012	46
20	The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa AIDS ·Lawrence Long,Matthew P. Fox,Ian Sanne,Sydney Rosen	2010	78

About Lawrence Long

Lawrence Long is a scholar working on Virology, Infectious Diseases, Emergency Medicine, Epidemiology and Economics and Econometrics, having authored 119 papers that have together received 3.0k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (87 papers), HIV Research and Treatment (33 papers), HIV/AIDS drug development and treatment (32 papers), HIV/AIDS Impact and Responses (27 papers), Tuberculosis Research and Epidemiology (20 papers), HIV, Drug Use, Sexual Risk (20 papers), Adolescent Sexual and Reproductive Health (18 papers) and Global Maternal and Child Health (17 papers). The work is most often cited by research in Virology (846 citations), Infectious Diseases (2.4k citations), Epidemiology (1.2k citations), Emergency Medicine (312 citations) and General Health Professions (557 citations). Lawrence Long has collaborated with scholars based in United States, South Africa and Netherlands. Frequent co-authors include Matthew P. Fox, Sydney Rosen, Ian Sanne, Alana T. Brennan, Mhairi Maskew, Kathryn Schnippel, Bruce A. Larson, Denise Evans, Gesine Meyer‐Rath and Constance Mongwenyana. Their work appears in journals such as PLoS ONE, Journal of the International AIDS Society, Tropical Medicine & International Health, AIDS and JAIDS Journal of Acquired Immune Deficiency Syndromes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact